Document is current
Any future updates will be listed below
-
Authors
Gläser, Eva
Kleinke, Fabian
Armanowski, Milena
Buchholz, Maresa
Fellgiebel, Andreas
Gerdes, Marius
Hoffmann, Wolfgang
Holle, Bernhard
Kilimann, Ingo
Köhler, Kerstin
Köhler, Stefanie
Maier, Franziska
Matthäus, Ingo
Pfeuffer, Nils
Rädke, Anika
Sarwinska, Dorota
Schott, Björn H.
Schwärzler, Frank
Swart, Enno
Teipel, Stefan
van den Berg, Neeltje
Wendisch, Tim
Wiltfang, Jens
Wuttke, Alexandra
Michalowsky, Bernhard
-
Funding
Funding for this research was provided by:
Federal Joint Committee (01NVF24315)
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
- License Information
-
More Information
Article History
Received: 27 November 2025
Accepted: 10 March 2026
First Online: 18 March 2026
Declarations
:
: The study protocol has been reviewed and was approved by the local Ethics Committee at University Medicine Greifswald (BB 076/25). In addition, secondary approvals were obtained from the local Ethics Committees at the State’s Chambers of Physicians ( Landesärztekammern ) Hesse, Baden-Wuerttemberg as well as from the Local Ethics Committees at the University Medical Center Göttingen (Lower Saxony), the Faculty of Medicine at the University of Cologne (North Rhine-Westphalia), University of Konstanz (Baden-Wuerttemberg) and University Medical Center Rostock (Mecklenburg-Western Pomerania).The study is conducted in full accordance with the ethical principles outlined in the Declaration of Helsinki, ensuring the protection of participants’ rights, safety, and well-being throughout all phases of the research [ ].
: The participant information materials and informed consent form are available from the corresponding author on request. No personal or clinical details of participants are presented here or will be presented in reports of the trial results.
: The authors declare that they have no competing interests.
